patient selection in treating hnscc
Published 7 years ago • 147 plays • Length 5:56Download video MP4
Download video MP3
Similar videos
-
5:01
patient selection for pembrolizumab in hnscc
-
4:35
patient selection for nivolumab in hnscc
-
5:02
multimodality treatment for hnscc
-
1:35
dr kirtane on an investigation of tils plus pembrolizumab in advanced hnscc
-
10:26
cetuximab or chemotherapy in hnscc?
-
4:19
skull base surgery at rush
-
4:57
johns hopkins head and neck cancer surgery center
-
3:56
cerebrovascular and skull base surgery - slu hospital
-
11:47
pembrolizumab in hnscc
-
11:57
immunotherapy in hnscc
-
1:52
safety of bca101, an egfr/tgfβ inhibitor, with pembrolizumab in hnscc
-
6:59
surveillance in hnscc
-
6:21
goals of therapy for hnscc
-
3:30
key points for treatment of advanced hnscc
-
8:58
practical issues surrounding immunotherapy for hnscc
-
7:38
pseudoprogression on immunotherapy in hnscc
-
6:22
long-term toxicity in hnscc
-
5:19
predictive biomarkers in hnscc
-
6:36
surgical management of hnscc
-
3:51
factors influencing treatment decisions for hnscc
-
9:40
emerging agents to treat hnscc
-
4:57
appropriate use of chemotherapy in hnscc